The shift to decentralised and hybrid clinical trials hasn't just changed how studies are run. It's changed what good looks like when you're hiring for the people who run them.
For years, the clinical research associate (CRA) role followed a familiar shape: travel to sites, review records, verify data, repeat. The competencies were well understood, the career ladder was visible, and hiring managers knew what they were looking for. Decentralised clinical trials (DCTs) haven't made that picture obsolete, but they've redrawn it substantially.
The DCT market is projected to reach USD 8.66 billion in 2025, growing at a CAGR of 14.8% through to 2034. That growth is not just a technology story. It's a workforce story, and the clinical operations teams scrambling to hire for it are discovering that the old job specs don't quite fit the new reality.
DCT market value, 2025
Projected CAGR through 2034
Sponsors now using remote source data review software
Traditional on-site monitoring hasn't vanished, but its dominance has. Sponsors and CROs are increasingly pushing monitoring activity to risk-based, centralised models, with CRAs managing data quality remotely rather than travelling site to site. Reports suggest that close to 97% of sponsors now use software to review source data remotely, which signals how far that shift has already gone.
"The move towards DCTs suggests that CRAs will increasingly operate as remote data specialists."
That transition asks something different of candidates. It's not that on-site skills become worthless. It's that technical proficiency with eClinical platforms, remote monitoring tools, and decentralised data flows has moved from "nice to have" to a baseline expectation. Candidates who can only function in a traditional site visit context are a narrower hire than they were five years ago.
There's also a subtler change in the interpersonal dimension. When a CRA builds a relationship with a site, they've historically done it in person. DCT models require those relationships to be maintained through screens and structured digital communication, which calls for a different kind of communication fluency. Hiring managers who haven't updated their interview frameworks for this gap will keep hiring the wrong people.
Beyond the evolution of existing functions, DCTs have created genuine demand for role profiles that were either niche or non-existent in most organisations five years ago.
Digital Health Coordinator: Integrates wearables, apps and remote monitoring into live studies
Centralised Monitor: Manages data quality and risk signals remotely across multiple sites
eCOA / eConsent Specialist: Oversees patient-facing digital tools and regulatory compliance
DCT Operations Manager: Coordinates home nursing, local labs and direct-to-patient logistics
Clinical Data Scientist: Works across wearables, ePRO and real-world evidence streams
Patient Experience Lead: Bridges retention strategy with digital engagement in remote studies
The challenge for hiring teams is that these profiles don't have deep talent pools yet. Candidates are often being hired on transferable skills and aptitude rather than a direct match to the job description. That makes sourcing and assessment harder, and it raises the stakes on getting the hiring process right.
The dominant model in 2025 isn't fully remote trials. It's selective decentralisation: baseline and key assessments at site, follow-ups via telehealth, labs shifted to local networks. That hybrid structure sounds logical on paper. In practice, it demands operational coordination across a much wider range of vendors, technology systems, and patient touchpoints than traditional trials ever required.
The people managing that coordination need a skill set that spans clinical rigour, technology literacy, vendor management, and patient communication. That's a lot to ask from a single hire, and it's why the industry is increasingly looking at how roles are structured rather than just how vacancies are filled. Some organisations are splitting responsibilities that were previously bundled together. Others are building specialist support functions around generalist trial leads. Neither approach works well without a clear view of what skills you actually have in your team versus what you're missing.
The competencies that consistently come up in conversations about DCT-ready talent aren't exotic. Adaptability. Technical proficiency with eClinical platforms. Strong remote communication. Comfort with ambiguity in a regulatory environment that's still evolving. The FDA's 2024 guidance on decentralised elements gave the industry more clarity, and the ICH E6(R3) revision reinforces the direction, but implementation is still being worked out across the sector.
What that means practically for hiring is that asking candidates about their experience with specific DCT technologies is necessary but not sufficient. The more revealing questions are about how they've navigated operational complexity in studies that didn't go to plan, how they've maintained site and patient relationships at a distance, and how they approach regulatory uncertainty in a fast-moving environment.
"DCT models are fundamentally about using fractional, remote, and community-based professionals to reach patients and stabilise operations, not just deploying technology."
Beyond which individuals to hire, DCTs are prompting a broader rethink of how clinical operations teams are structured. The organisations managing this well have moved away from fixed headcount towards what some are calling capacity pods: a core of permanent staff for continuity, supported by a flexible bench of contractors and remote-ready professionals who can be deployed for enrollment peaks, site start-up phases, or specialist tasks.
That model suits DCTs well because it mirrors the study structure itself. Remote-ready flexibility, modular by design, with oversight maintained at the centre. It also creates a different sourcing challenge. The talent partners who can support that model need to understand not just what roles look like, but how they interact with the wider operational architecture of a decentralised study.
The clinical research workforce has always been shaped by what trials actually require. DCTs are pulling it in a new direction quickly, and not all organisations are keeping pace. Training pipelines haven't fully caught up. Academic institutions are only beginning to integrate DCT operations into health sciences curricula. And the candidates who do have genuine DCT experience are in demand across multiple sponsors and CROs at once.
That scarcity makes the quality of your hiring process matter more than it used to. Organisations that can identify DCT-capable talent early, assess for adaptability as well as credentials, and structure roles that reflect how decentralised studies actually work will be better positioned. Those that keep running the same process and wondering why they can't find the right people will keep not finding them.
Vector Talent specialises in clinical operations hiring across sponsor and CRO environments. If you're building out a DCT-capable team or looking for your next role in decentralised research, get in touch with the team at Vector.